RESMED INC. DL-,004/ US7611521078 /
4/25/2024 4:00:11 PM | Chg. -3.20 | Volume | Bid4:00:12 PM | Ask3:59:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
169.45EUR | -1.85% | 0 Turnover: 0.00 |
-Bid Size: - | -Ask Size: - | 27.95 bill.EUR | - | - |
GlobeNewswire
5/23
Developed in Collaboration with Leading Scientists, New ResMed-Supported Research at ATS 2024 Provid...
GlobeNewswire
5/16
ATS 2024: New ResMed-Supported Research Shows Increasing Prevalence of Obstructive Sleep Apnea and ...
GlobeNewswire
5/16
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
5/7
XEALTH AND STEL LIFE TEAM UP, CONNECTING PATIENT HEALTH DEVICES AND CARE TEAMS VIA CELLULAR NETWORKS
GlobeNewswire
4/10
CHILDREN’S WISCONSIN REMOTELY MONITORING PEDIATRIC PATIENTS VIA XEALTH AND LOCUS HEALTH
GlobeNewswire
3/6
Introducing the AirFit F40: Experience Unprecedented Freedom with the Comfort and Optimized Seal Per...
GlobeNewswire
3/5
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
GlobeNewswire
2/15
ACELYRIN, INC. Appoints Agnes Lee as Senior Vice President, Investor Relations and Corporate Communi...
GlobeNewswire
2/12
ResMed’s New AirCurve™ 11 Bilevel Devices Enable Healthcare Providers to Make Informed Decisions abo...
GlobeNewswire
2/6
Vivos Therapeutics Highlights Significant Favorable Market Developments Creating Exciting New Growth...